BeOne Medicines AG
ONC
$335.17
$2.460.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 202.88% | 178.34% | 100.51% | 58.27% | -160.81% |
| Total Depreciation and Amortization | -49.01% | 25.73% | 31.19% | 99.00% | 270.95% |
| Total Amortization of Deferred Charges | 29.60% | 388.45% | -0.85% | 26.48% | 171.83% |
| Total Other Non-Cash Items | 30.06% | 13.25% | 21.19% | 6.64% | 129.14% |
| Change in Net Operating Assets | -23.34% | 104.72% | 49.78% | 57.58% | -60.68% |
| Cash from Operations | 113.70% | 375.76% | 114.29% | 128.21% | 59.30% |
| Capital Expenditure | 64.02% | 60.14% | 63.98% | 29.86% | 25.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -424.23% | -2,005.27% | -23.06% | 25.10% | -100.09% |
| Cash from Investing | 63.20% | 40.01% | 41.89% | 26.86% | -270.24% |
| Total Debt Issued | -- | -22.40% | -47.05% | 9.62% | -100.00% |
| Total Debt Repaid | -19.71% | 31.25% | -4,849.32% | -261.30% | 99.50% |
| Issuance of Common Stock | 396.42% | 495.69% | 328.36% | 235.15% | -87.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | 6.81% |
| Other Financing Activities | -- | -- | -- | 20.99% | 100.00% |
| Cash from Financing | 7,491.79% | 52.17% | -120.81% | -92.11% | 111.24% |
| Foreign Exchange rate Adjustments | -65.06% | 497.78% | 115.51% | -250.16% | -50.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,286.91% | 234.82% | 71.43% | 57.59% | -32.52% |